The Blood Sugar Study

GLP-1 (glucagon-like peptide 1) is a naturally occurring hormone in the intestine and brain and primarily serves to control blood sugar levels, appetite and stomach emptying.

This medication has been developed as an oral tablet that mimics the actions of GLP-1 for management of type 2 diabetes mellitus, obesity and non-alcoholic steatohepatitis (NASH, a liver inflammation associated with diabetes and/or obesity rather than viral infection or alcohol drinking).

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.